← Open Payments lookup

ANTON KOOPMAN: Open Payments

NPI 1538182035 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$848 in 39 payments from 15 companies in 2025. Trend: 2023 $915 · 2024 $870 · 2025 $848

Food & beverage: $848
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$322
Lilly USA, LLC6$88
ABBVIE INC.5$85
Axsome Therapeutics, Inc.3$76
Novo Nordisk Inc4$65
Abbott Laboratories2$38
GlaxoSmithKline, LLC.2$34
Avvisto Therapeutics, LLC2$31
Phathom Pharmaceuticals, Inc.1$20
Otsuka America Pharmaceutical, Inc.1$17

Products named: FARXIGA, Auvelity, VRAYLAR, MOUNJARO, FREESTYLE LIBRE 3, Wegovy, TRELEGY ELLIPTA, CYCLOSET.

Industry payments across IN — which companies pay providers there.